Clinical Trial Update: Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State [Phase 2]

View source ↗

Summary

Phase 2 safety study of ziprasidone (Geodon) for depressive mixed state in bipolar disorder has completed, with results posted in January 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: Tufts Medical Center | Conditions: Bipolar Disorder, Bipolar Depression | Phase 2 | Status: COMPLETED | Results posted: 2014-01-08